Skip to content

Replimune Group REPL Income Statement

TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25TTM Q3 '25
$222.84M+2.4%$217.7M+7.1%$203.27M+7.9%$188.4M+6.4%$177M+3.0%
$103.07M+0.7%$102.36M+12.0%$91.42M+24.8%$73.23M+14.3%$64.06M+7.2%
$325.91M+1.8%$320.06M+8.6%$294.69M+12.6%$261.63M+8.5%$241.06M+4.1%
$325.91M+1.8%$320.06M+8.6%$294.69M+12.6%$261.63M+8.5%$241.06M+4.1%
-$325.91M-1.8%-$320.06M-8.6%-$294.69M-12.6%-$261.63M-8.5%-$241.06M-4.1%
$5.89M+0.3%$5.87M+0.9%$5.82M+0.8%$5.78M+0.8%$5.73M+8.3%
$17.13M-11.8%$19.42M-8.0%$21.12M0.0%$21.12M+2.1%$20.68M-2.6%
$10.64M+3.6%$10.27M-31.3%$14.94M+0.9%$14.8M+11.1%$13.33M-29.7%
-$246.83M-8.4%-$227.73M-7.1%
-$314.85M-1.5%-$310.26M-10.7%-$280.22M-13.3%-$247.3M-8.3%-$228.24M-7.1%
-$3.44+0.6%-$3.46-6.8%-$3.24-5.5%-$3.070.0%-$3.07-0.7%
-$3.44+0.6%-$3.46-6.8%-$3.24-5.5%-$3.070.0%-$3.07-0.7%
356.2M+2.5%347.5M+4.0%334.1M+7.2%311.8M+4.7%297.8M+6.0%
356.2M+2.5%347.5M+4.0%334.1M+7.2%311.8M+4.7%297.8M+6.0%
$17.13M-11.8%$19.42M-8.0%$21.12M0.0%$21.12M+2.1%$20.68M-2.6%
$5.89M+0.3%$5.87M+0.9%$5.82M+0.8%$5.78M+0.8%$5.73M+8.3%
$1.69M-2.0%$1.72M-1.8%$1.76M-1.0%$1.77M-6.2%$1.89M-2.0%
-$325.91M-1.8%-$320.06M-8.6%-$294.69M-12.6%-$261.63M-8.5%-$241.06M-4.1%
-$322.59M-1.9%-$316.54M-8.8%-$291.06M-12.8%-$258.15M-8.6%-$237.72M-4.0%
-$322.59M-1.9%-$316.54M-8.8%-$291.06M-12.8%-$258.15M-8.6%-$237.72M-4.0%
-$325.91M-1.8%-$320.06M-8.6%-$294.69M-12.6%-$261.63M-8.5%-$241.06M-4.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Replimune Group profitable?
Replimune Group is not currently profitable: it reported a net loss of $314.9M over the trailing twelve months.
What is Replimune Group's earnings per share?
Replimune Group's diluted EPS over the trailing twelve months is $-3.44.
Where does Replimune Group's income statement data come from?
Every line is extracted from Replimune Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.